Activity Preview


Psychiatry Over the Horizon: Advances in Research Part 1

Activity Type:

  • On Demand

Release Date: 8/20/2015

Expiration Date: 8/20/2018

  • AMA PRA Category 1 Physician: 2
  • Participation: 2

Access Activity


Psychiatry as a discipline embraces a wide variety of approaches. This course will highlight some of those contributions to the rich field of Psychiatry. One of the remarkable aspects of the diverse scholarly arenas which relate to psychiatry is the increasing tendency for overlap. What for example are the genes that are consequential in the pathophysiology of psychiatric disorders, and how do they relate to clinical aspects of psychiatry? In looking at illnesses such as Schizophrenia and bipolar disease, what do we know about dysfunctional neuro-circuits that are tied to clinical symptoms? Increasingly we are searching for specific treatments targeted at specific types of Schizophrenia or other illnesses. What's the evidence for effectiveness of psychotherapy for such illnesses? An increasing synthesizing theme is moving toward personalized medicine which will generate more closely targeted treatments to specific illnesses and hopefully improved outcomes. How does the disturbing data regarding the global and impressively large prevalence of psychiatric illness relate to treatment capacity? Who will see whom? How will we handle the needs for far greater numbers of providers and capacity for treatment of psychiatric disorders? What's the role of integrated primary care and psychiatry? And at the same time how do Genetic studies, Imaging studies, Neurobiological Circuits, Therapeutic research and Epidemiology pull together to provide the practicing Psychiatrist with increasingly effective tools to address the problems brought to them? This outstanding group of leaders from diverse fields will provide the audience with a crisp and broad understanding of the latest concepts and techniques, and the possibilities for improvement in diagnosis and therapeutics.

**This content was captured at the 2014 APA Annual Meeting


  • General Member - $30.00
  • Resident-Fellow Member - Free
  • Medical Student Member - $30.00
  • Non-Member - $60.00

Educational Objectives

  • Recognize the importance of diverse disciplines to the understanding and diagnosis and treatment of psychiatric illnesses
  • Describe the linkage between current research in one of the areas and clinical significance 
  • Demonstrate an enhanced understanding of research developments and efforts going forward. 

Target Audience

Residents/Fellows and Psychiatrists

Estimated Time to Complete

2 Hours

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 50% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate showing the date of completion and hours earned. 


The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures


  • Jeffery A. Lieberman, M.D., Columbia University Medical Center | Disclosure: Grant/Research Support - Glaxo Pharmaceuticals|Hoffman-LaRoche Pharmaceuticals | Eli Lilly and Company | Merck & Co. | Novartis Pharmaceuticals Corporation | Pfizer | Sunovion Pharmaceuticals Inc. | BioMarin | Targacept | Genentech | GlaxoSmithKline | Stock/Other financial relationship - Eli Lilly and Company | Pierre Fabre | Allon Therapeutics | Repligen | Other - Board member for Bioline, Intracellular Therapies, Eli Lilly, Pierre Fabre, and PsychoGenics Receiving grants or grants pending: Sepracor (Sunovion), Psychogenics holding a patent (planned, pending or issued) from Repligen; receiving a patent pending from Allon 
  • Herbert Pardes, M.D., New York-Presbyterian Hospital | Disclosure: Reports no financial relationships with commercial interests


  • Glen O. Gabbard, M.D., The Gabbard Center | Disclosure: Reports no financial relationships with commercial interests
  • William T. Carpenter, M.D., University of Maryland School of Medicine | Disclosure: Reports no financial relationships with commercial interests
  • Cameron Carter, M.D., University of California | Disclosure: Reports no financial relationships with commercial interests
  • Sander Markx, M.D., New York-Presbyterian Hospital | Disclosure: Reports no financial relationships with commercial interests

Program Planners:

  • Tristan Gorrindo, M.D., Director of Education, American Psychiatric Association | Disclsoure: Reports no financial relationships with commercial interests
  • Ricardo Juarez, Associate Director, Office of International Affairs, American Psychiatric Association | Disclosure: Reports no financial relationships with commercial interests

Hardware/Software Requirements

Hardware/Software Specifications:
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

For assistance: Contact for questions about this course | Contact for technical assistance

Access Activity